Compare INUV & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 61.1M |
| IPO Year | N/A | N/A |
| Metric | INUV | DXR |
|---|---|---|
| Price | $2.56 | $13.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $14.00 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 105.1K | 2.6K |
| Earning Date | 11-06-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $98,139,861.00 | $66,306.00 |
| Revenue This Year | $20.86 | N/A |
| Revenue Next Year | $14.59 | N/A |
| P/E Ratio | ★ N/A | $38.57 |
| Revenue Growth | ★ 25.11 | N/A |
| 52 Week Low | $2.34 | $6.55 |
| 52 Week High | $7.90 | $14.15 |
| Indicator | INUV | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 63.46 |
| Support Level | $2.50 | $12.00 |
| Resistance Level | $2.77 | $12.90 |
| Average True Range (ATR) | 0.17 | 0.41 |
| MACD | -0.02 | 0.14 |
| Stochastic Oscillator | 11.65 | 100.00 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.